Racial and Ethnic Disparities in Severe Ischemic Manifestations and Tocilizumab Use Among Patients With Giant Cell Arteritis: A Nationwide Retrospective Cohort Study Using TriNetX

Key Points

• This research aims to investigate racial and ethnic disparities in severe ischemic manifestations and tocilizumab use among patients with giant cell arteritis.
• Utilized a nationwide retrospective cohort design using TriNetX database.
• Analyzed differences in severe ischemic manifestations between non-White and White patients.
• Examined treatment variations with tocilizumab among Black, Hispanic, and White patients.
• Significant differences in severe ischemic manifestations were found between non-White and White patients.
• Disparities in tocilizumab use were observed between Black and White patients, and Hispanic and White patients.
• No significant differences in treatment were noted between Asian and White patients.